Literature DB >> 12368357

Evidence for early infection of nonneoplastic natural killer cells by Epstein-Barr virus.

Pascal Trempat1, Julie Tabiasco, Pascale Andre, Nathalie Faumont, Fabienne Meggetto, Georges Delsol, Randy D Gascoyne, Jean-Jacques Fournie, Eric Vivier, Pierre Brousset.   

Abstract

We examined lymph nodes and tonsils from patients with infectious mononucleosis by combined detection of EBV-encoded RNA and a specific marker of natural killer (NK) cells, PEN5. A small number of Epstein-Barr virus (EBV) latently infected nonneoplastic NK cells were detected. Our data demonstrate that NK cells are natural targets of EBV and that infection of these cells is an early event observed during primary EBV infection.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12368357      PMCID： PMC136608          DOI： 10.1128/jvi.76.21.11139-11142.2002

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  16 in total

1.  Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus.

Authors:  Corina M Borza; Lindsey M Hutt-Fletcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

2.  Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism.

Authors:  J W Sixbey; Q Y Yao
Journal:  Science       Date:  1992-03-20       Impact factor: 47.728

3.  Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes.

Authors:  E Fischer; C Delibrias; M D Kazatchkine
Journal:  J Immunol       Date:  1991-02-01       Impact factor: 5.422

4.  Identification of tissue-infiltrating lymphocytes expressing PEN5, a mucin-like glycoprotein selectively expressed on natural killer cells.

Authors:  E Vivier; M Munroe; P Ariniello; P Anderson
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

Review 5.  EBV-NK cells interactions and lymphoproliferative disorders.

Authors:  H Kanegane; A Yachie; T Miyawaki; G Tosato
Journal:  Leuk Lymphoma       Date:  1998-05

6.  Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.

Authors:  L Quintanilla-Martinez; S Kumar; F Fend; E Reyes; J Teruya-Feldstein; D W Kingma; L Sorbara; M Raffeld; S E Straus; E S Jaffe
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

7.  Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.

Authors:  Y Kasahara; A Yachie; K Takei; C Kanegane; K Okada; K Ohta; H Seki; N Igarashi; K Maruhashi; K Katayama; E Katoh; G Terao; Y Sakiyama; S Koizumi
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

8.  Epstein-Barr virus distribution in nonneoplastic lymph nodes.

Authors:  F D Deamant; P F Albújar; Y Y Chen; L M Weiss
Journal:  Mod Pathol       Date:  1993-11       Impact factor: 7.842

9.  Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus.

Authors:  P Kanavaros; M C Lescs; J Brière; M Divine; F Galateau; I Joab; J Bosq; J P Farcet; F Reyes; P Gaulard
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

10.  Developmental regulation of a mucinlike glycoprotein selectively expressed on natural killer cells.

Authors:  E Vivier; J M Sorrell; M Ackerly; M J Robertson; R A Rasmussen; H Levine; P Anderson
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307
View more
  10 in total

Review 1.  Peripheral T cell lymphomas: from the bench to the clinic.

Authors:  Danilo Fiore; Luca Vincenzo Cappelli; Alessandro Broccoli; Pier Luigi Zinzani; Wing C Chan; Giorgio Inghirami
Journal:  Nat Rev Cancer       Date:  2020-04-06       Impact factor: 60.716

Review 2.  Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.

Authors:  Lindsay C George; Martin Rowe; Christopher P Fox
Journal:  Curr Hematol Malig Rep       Date:  2012-12       Impact factor: 3.952

Review 3.  The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.

Authors:  A A Gru; B H Haverkos; A G Freud; J Hastings; N B Nowacki; C Barrionuevo; C E Vigil; R Rochford; Y Natkunam; R A Baiocchi; P Porcu
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

4.  Replication of Epstein-Barr virus primary infection in human tonsil tissue explants.

Authors:  Kensei Gotoh; Yoshinori Ito; Seiji Maruo; Kenzo Takada; Terukazu Mizuno; Masaaki Teranishi; Seiichi Nakata; Tsutomu Nakashima; Seiko Iwata; Fumi Goshima; Shigeo Nakamura; Hiroshi Kimura
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

5.  Aggressive NK-cell leukemia in a 69 years old Caucasian woman: a case report.

Authors:  Sara Maj Hyldig Matzen; Klaus Kallenbach; Anne Regitze Reumert; Lars Munksgaard
Journal:  Springerplus       Date:  2015-12-09

Review 6.  Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders.

Authors:  Akihisa Sawada; Masami Inoue
Journal:  Front Pediatr       Date:  2018-11-06       Impact factor: 3.418

Review 7.  Viral Infection of Human Natural Killer Cells.

Authors:  Elisabeth A van Erp; Mirjam R van Kampen; Puck B van Kasteren; Jelle de Wit
Journal:  Viruses       Date:  2019-03-12       Impact factor: 5.048

8.  Revisiting the Tissue Microenvironment of Infectious Mononucleosis: Identification of EBV Infection in T Cells and Deep Characterization of Immune Profiles.

Authors:  Mário Henrique M Barros; Gabriela Vera-Lozada; Priscilla Segges; Rocio Hassan; Gerald Niedobitek
Journal:  Front Immunol       Date:  2019-02-20       Impact factor: 7.561

9.  Uncovering early events in primary Epstein-Barr virus infection using a rabbit model.

Authors:  Narendran Reguraman; Asma Hassani; Pretty Philip; Gulfaraz Khan
Journal:  Sci Rep       Date:  2021-10-27       Impact factor: 4.379

10.  Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases.

Authors:  Wiyada Wongwiwat; Benjamin Fournier; Irene Bassano; Amr Bayoumy; Claudio Elgueta Karstegl; Christine Styles; Ray Bridges; Christelle Lenoir; David BoutBoul; Despina Moshous; Bénédicte Neven; Teru Kanda; Rhys G Morgan; Robert E White; Sylvain Latour; Paul J Farrell
Journal:  J Virol       Date:  2022-05-25       Impact factor: 6.549
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.